MedTrace Logo

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

NCT02908126 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-11-22

No results posted yet for this study

Summary

This is a Phase I open-label, parallel-group clinical study in healthy term pregnant females undergoing a caesarean section. Two administrations of oxytocin will be tested, after which uterine contractility will be assessed.

Conditions

  • Post Partum Haemorrhage

Interventions

DRUG

Oxytocin

Oxytocin drug

Sponsors & Collaborators

  • Oxytone Bioscience BV

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-03
Primary Completion
2019-06-27
Completion
2019-06-27

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02908126 on ClinicalTrials.gov